In order to prevent spam,
this email address cannot be copied.
Schizophrenia Research Forum: Researcher Profile - Jan Volavka
Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
News
Research News
Conference News
Plain English
Forums
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
Interviews
Resources
What We Know
SchizophreniaGene
Animal Models
Drugs in Trials
Research Tools
Grants
Jobs
Conferences
Journals
Community Calendar
General Information
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
History
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Researcher Profile - Jan Volavka

RESEARCHER INFORMATION
First Name:Jan
Last Name:Volavka
Title:Professor of Psychiatry Emeritus
Advanced Degrees:MD PhD
Affiliation:retired
Street Address 1:P.O. Box 160663
City:Big Sky
State/Province:MT
Zip/Postal Code:59716-0663
Country/Territory:U.S.A.
Email Address: janvolavka@gmail.com
Disclosure:
(view policy) 
Member reports no financial or other potential conflicts of interest. [Last Modified: 20 October 2005]
View all comments by Jan Volavka
Clinical Interests:
Schizophrenia
Research Focus:
Pharamacology, aggression
Work Sector(s):
retired
Reasearcher Bio


Curriculum Vitae

Jan Volavka



Personal Data

Born Prague, Czech Republic
Citizenship United States of America
Marital Status Married, Oct. 26 1986 to Jana Houskova
Children Nicole Volavka, June 10 1973




EDUCATION
Year Degree Field Institution
1953 BA Biology Fucikovo College, Prague
1959 MD Medicine Charles University, Prague
1965 PhD Medical Science, Academy of Sciences, Prague
Clin. Electrophysiology




Postdoctoral Training:
See above


Internships and Residencies:

1959-63 Internship and Residency in Psychiatry, Horni Berkovice Hospital, Czech Republic
1969-71 Residency in Psychiatry, New York Medical College




Clinical and Research Fellowships:

1963-1966 Research Psychiatrist Psychiatric Research Institute, Prague
1966-1967 Visiting Fellow Dept. of Neurology, The London Hospital, London, UK
1967-1968 Clinical Research Psychiatrist Psychiatric Research Institute, Prague
1968-1969 Visiting Scientist Max Planck Institute for Psychiatry, Munich, Germany


Licensure and Certification
1973 New York State License Registration # 115495
1975 American Board of Psychiatry & Neurology Board Cert. Psychiatry Certificate #14030


Academic Appointments

1969-1973 Assistant Professor Department of Psychiatry, New York Medical College
1973-1976 Associate Professor Department of Psychiatry, New York Medical College
1976-1979 Professor of Psychiatry Missouri Institute of Psychiatry, Univ. of Missouri
1979-2005 Professor of Psychiatry New York University School of Medicine, New York



Hospital Appointments

1979-1985 Director of Research Manhattan Psychiatric Center, New York



Awards and Honors

1988 Award for Excellence in Research - New York State Office of Mental Health
Top Papers
42. Volavka J, Mallya A, Baig S, Perez-Cruet J. Naloxone in chronic schizophrenia. Science. 1977;196:1227-1228.
53. Volavka J, Cho D, Mallya A, Bauman J. Naloxone increases ACTH and cortisol levels in man. N Engl J Med. 1979;300:1056-1057.
111. Volavka J, Cooper T, Czobor P, Bitter I, Meisner M, Laska E, Gastanaga P, Krakowski M, Chou JCY, Crowner M, Douyon R. Haloperidol blood levels and clinical effects. Arch Gen Psychiatry. 1992;49:354-361.
122. Volavka J, Cooper TB, Czobor P, Meisner M. Plasma haloperidol levels and clinical effects in schizophrenia and schizoaffective disorder. Arch Gen Psychiatry. 1995;52:837-845.
130. Volavka J, Laska E, Baker S, Meisner M, Czobor P, Krivelevich I. History of violent behaviour and schizophrenia in different cultures. Analyses based on the WHO study on determinants of outcome of severe mental disorders. Br J Psychiatry. 1997;171:9-14.
147. Bilder RM, Goldman RS, Volavka J, Czobor P, Hoptman M, Sheitman B, Lindenmayer JP, Citrome L, McEvoy J, Kunz M, Chakos M, Cooper TB, Horowitz TL, Lieberman JA. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry. 2002;159:1018-1028.
150. Volavka J, Czobor P, Sheitman B, Lindenmayer J-P, Citrome L, McEvoy J, Cooper TB, Chakos M, Lieberman JA. Clozapine, olanzapine, risperidone, and haloperidol in treatment-resistant patients with schizophrenia and schizoaffective disorder. Am J Psychiatry. 2002;159:255-262.
151. Lindenmayer JP, Czobor P, Volavka J, Citrome L, Sheitman B, McEvoy JP, Cooper TB, Chakos M, Lieberman JA. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. Am J Psychiatry. 2003;160:290-296.
153. Bilder RM, Volavka J, Lachman HM, Grace AA. The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology. 2004;29:1943-1961.
157. Volavka J, Czobor P, Nolan K, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Cooper TB, Lieberman JA. Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol. J Clin Psychopharmacol. 2004;24:225-228.


What are the top three papers (not yours) you have read recently?

1. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353:1209-1223.
2. Teplin LA, McClelland GM, Abram KM, Weiner DM. Crime victimization in adults with severe mental illnesse: comparison with the National Crime Victimization Survey. Arch Gen Psychiatry. 2005;62:911-921.
3. Ho BC, Wassink TH, O'Leary DS, Sheffield VC, Andreasen NC. Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow. Mol Psychiatry. 2005;10:229, 287-229, 298.



Research Participants
Collaborators
Copyright © 2005- 2014 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright